move to main move to category
  1. HOME
  2. News Release

News Release

2016

Dec 28
The SBI Group and IBM Japan to Launch Joint Venture Offering Support to Regional Financial Institutions in FinTech Service Implementation
(54.8 KB)
Dec 9
Notice on the Joint Establishment with Neopharma, U.A.E. of an Enterprise to Distribute 5-ALA-Related Products
(121.1KB)
Oct 26
Exclusive License Agreement Concluded with Neopharma on the Therapeutic Drugs for Diabetes and Malaria Infection
(122.7KB)
Oct 25
Official Launch of “The Japan Bank Consortium to Central Provide Domestic and Cross-border Payment”
(112.2KB)
Oct 21
SBI Biotech’s Licensed Product, an Anti-ILT7 Antibody (MEDI7734*) Has Achieved a Developmental Milestone in a Phase I Clinical Trial
(134.7KB)
Oct 20
SBI BITS Launches New ALPHA8 Trader Workstation
(237.9KB)
Oct 18
Interim Results Announcement for the Six Months Ended September 30, 2016 of SBI SECURITIES
(100.9KB)
Sep 29
Interim Dividend Forecast for the Fiscal Year Ending March 31, 2017
(72.9KB)
Sep 28
Notice Regarding the Appointment of Ms. Satoko Yahata,the Senior Advisor of the Company, as the Brand Ambassador of Sri Lanka
(68.3KB)
Sep 26
Research Paper on the Safety and Usefulness of 5-ALA in the Patients with Type 2 Diabetes in Bahrain in the Food Intervention Test Published in the “Journal of Diabetes Research”
(154.5KB)
Sep 6
Result and Completion of Share Repurchase (Repurchase of Company Shares Pursuant to the Articles of Incorporation and the Provisions of Article 165, Paragraph 2 of the Corporate Law)
(73.1KB)
Sep 5
Establishment of a FinTech Joint Venture Company Together with Carret Private Investment Limited and Carpal Investment Group Limited
(71.1KB)
Aug 19
Launch of Consortium for Considering Using Blockchain Technology to Centrally Provide Domestic and Foreign Exchange Services
(93.4KB)
Jul 28
Notice Regarding Purchase of the Company’s Own Shares (Repurchase of Company Shares Pursuant to the Articles of Incorporation and the Provisions of Article 165, Paragraph 2 of the Corporate Law)
(80.5KB)
Jul 20
Registration of a U. S. Patent for Treatment of Influenza Virus Infection through Joint Application with Tokushima University
(37.5KB)
Jul 20
Registration of a U. S. Patent on the External Preparation for Skin Containing 5-ALA
(72.1KB)
Jul 19
Mizuho and SBI Trial Cross-Border Payments Utilizing Blockchain Technology The first collaborative project with the R3 Consortium in Japan
(185.1KB)
Jul 19
First Quarterly Results Announcement for the Three Months Ended June 30, 2016 of SBI SECURITIES
(39.9KB)
Jul 4
Establishment of Private Fund Jointly With Nikon Corporation
(89.4KB)
Jun 30
Completion of Solicitation for the FinTech Fund, a Venture Capital Fund Targeting FinTech-related Companies
(89.7KB)
Jun 23
Notice Regarding Share Acquisition of a Subsidiary of Philippines Financial Group “ICCP”
(70.4KB)
Jun 14
Ripple, a JV Partner of SBI Ripple Asia, Receives New York's BitLicense
(148.4KB)
May 30
Listing of Phnom Penh SEZ in Cambodia with SBI Royal Securities Serving as Its Lead Manager
(78.8KB)
May 26
Overview of Evaluation Results on Effectiveness of Company’s Board of Directors
(27.3KB)
May 20
Registration of a Patent for Treatment and Prevention of Radiation Damage through Joint Application with The University of Tokyo
(94.7KB)
May 20
Registration of a Patent for Enhancer of Survival of Transplanted Organ through Joint Application with National Center for Child Health and Development
(93.4KB)
May 19
Establishment of SBI Ripple Asia as a Provider of a Next-Generation Settlement Platform Based on Block Chain Technology
(84.2KB)
May 18
Registration of a Patent for Treatment and Prevention of Influenza Virus Infection through Joint Application with Tokushima University
(85.0KB)
May 9
Agreement in Principle for the Acquisition of Fukuroi Factory of API Corporation
(47.9KB)
Apr 28
Notice Regarding Distribution of Retained Earnings
(76.8KB)
Apr 28
Notice regarding Adjustment of Conversion Price for \30,000,000,000 Zero Coupon Convertible Bonds Due 2017
(33.8KB)
Apr 28
Notice Regarding Changes in Officers
(84.9KB)
Apr 19
Notice Regarding Distribution of Retained Earnings
(76.8KB)
Apr 28
Annual Results Announcement for the Year Ended March 31, 2016 of SBI SECURITIES
(44.4KB)
Apr 12
Notice Regarding an Investment into a SME-Focused Bank in Indonesia
(77.4KB)
Mar 18
Result and Completion of Share Repurchase (Repurchase of Company Shares Pursuant to the Articles of Incorporation and the Provisions of Article 165, Paragraph 2 of the Corporate Law)
(72.8KB)
Mar 16
Registration of a Patent on a Device to Identify Cancer Metastasis in Sentinel Lymph Node
(82.0KB)
Mar 15
Registration of a Patent for Photodynamic Therapy Using a Photosensitizer or 5-Aminolevulinic Acids
(81.9KB)
Mar 14
Registration of a Patent for Photodynamic Diagnosis and Photobleaching-Prevention Agent through Joint Application with Tokyo Institute of Technology
(83.8KB)
Mar 14
Registration of a Patent for Treatment and Prevention of Chronic Kidney Disease
(81.7KB)
Mar 14
Registration of a Patent for Treatment and Prevention of Cancer Anemia
(81.3KB)
Mar 14
Joining Blockchain Consortium R3 Led by R3 CEV, a U.S. FinTech Company
(192.2KB)
Feb 25
Notice Regarding Purchase of the Company's Own Shares (Repurchase of Company Shares Pursuant to the Articles of Incorporation
and the Provisions of Article 165, Paragraph 2 of the Corporate Law)
(172.0KB)
Feb 25
Revision of Dividend Forecast for the Fiscal Year Ending March 31, 2016
(113.7KB)
Feb 5
Notice Regarding the Agreement of Share Transfer of Phnom Penh Commercial Bank
(79.0KB)
Jan 29
Notice of Memorandum of Understanding on Investing in and Establishing Joint Venture with Ripple Labs Inc. that develops “Ripple Connect,” a Next-generation Settlement Platform based on Blockchain Technology
(89.8KB)
Jan 29
Notice of Memorandum of Understanding on Investment in bitFlyer, Inc.
(85.9KB)
Jan 29
Notice of Memorandum of Understanding on Investment in Payward, Inc, an U.S. Start-up Company that Operates “Kraken,” an Exchange of Virtual Currency Including Bitcoin
(88.0KB)
Jan 29
Notice of Investment in FUNDBOX LTD., a U.S. FinTech Company
(89.8KB)
Jan 19
Third Quarterly Results Announcement for the Nine Months Ended December 31, 2015 of SBI SECURITIES
(44.4KB)
Jan 15
Notice on Acquisition of Additional Equity Interest in German Biotech Firm Engaged in 5-ALA-Related Drug Business in Europe (to Make it a Subsidiary)
(48.2KB)
Get Acrobat Reader
Adobe Reader
You need to download Adobe Reader to view these PDF files.
  • There is no charge for downloading Adobe Reader.
  • The logos of Adobe Reader and Adobe Reader are the registered trademarks of Adobe Systems.

News